China just carried out its second reusable launch attempt in three weeks

China’s state-owned CASC launched the first Long March 12A — a reusable, methane-fueled medium-class rocket roughly the size of a Falcon 9 — from Jiuquan and its upper stage successfully reached the mission’s predetermined low-Earth orbit. The first-stage booster failed to complete a braking burn and impacted roughly 200 miles downrange, prompting CASC to launch a technical investigation; the outcome echoes a similar December 2 Zhuque-3 debut where the recoverable booster was also lost. The partial success advances flight-validated engineering data but raises near-term questions about reusable-stage recovery reliability and the economics of China’s emerging reusable-rocket sector.

Analysis

Market structure: China’s repeat first‑flight orbital success (but failed recovery) benefits state-backed launch integrators and downstream satellite operators that value high cadence and lower per‑kg pricing; expect increasing pricing pressure on small western commercial launchers (potential downward pricing pressure of 10–30% over 3–5 years if China scales). Direct losers: early‑stage pure‑play small launchers and launch insurers; winners: large defense primes (LMT, NOC, BA) that win government spending and domestic launch subsidies.

Risk assessment: Tail risks include rapid escalation of export controls or space‑military competition (low probability, high impact — 5–15% chance over 12–36 months) and rising insurance/financing costs for private launchers (could lift premiums +20–50%). Immediate (days): volatility spikes in small‑cap launchers; short term (weeks–months): funding stress for startups; long term (years): potential commoditization of launch lowers margins for commercial providers.

Trade implications: Prefer reweight toward large aerospace & defense and away from small commercial launchers. Tactical options: use cost‑limited puts on small launchers to express downside volatility and buy 12‑month call spreads on defense primes to capture budget tailwinds. Cross‑asset: modest upward pressure on EM/China corporate bonds if industrial export narrative strengthens; negligible commodity impact (fuel demand immaterial).

Contrarian angles: Consensus downplays the significance of two back‑to‑back orbital successes — even without recovery this signals engineering maturity that can accelerate China’s cadence. Market may be overpricing failure risk in western small launchers; history (SpaceX early failures) suggests repeated flights + iterative fixes can flip economics quickly, so position sizing and triggers must be discipline‑based.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Lockheed Martin (LMT) and a 2–3% long in Northrop Grumman (NOC) each, using 12‑month horizon; trim if combined defense‑space contract awards fall >20% QoQ or if either stock underperforms the S&P 500 by >10% in 90 days.
• Establish 1–2% notional short exposure to small western launchers (Rocket Lab RKLB, Astra ASTR) via 3‑month 25‑delta put spreads (cost‑limited) sized to risk no more than 0.5–1.0% portfolio loss; close or reduce if implied volatility drops below 30% or if either company proves two consecutive successful recoveries within 6 months.
• Implement a pair trade: long LMT (1.5% notional) vs short RKLB (1.5% notional) to capture structural shift; rebalance after material catalysts — reduce short by 50% if China records two successful recoveries within a 6‑month window, otherwise maintain for 6–12 months.
• Allocate 1% to a 9–12 month call spread on Maxar Technologies (MAXR) 15–25% OTM to play increased geospatial/defense demand; exit on strong US/Allied space procurement announcements or if MAXR rises >30% from entry.